Skip to content

Atrial Strain in Septic Shock

Assessment of Left And Right Atrial Strain in Septic Shock

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06832436
Acronym
ALARMS
Enrollment
60
Registered
2025-02-18
Start date
2025-03-06
Completion date
2026-09-01
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Care, Echocardiographic Software, Left Atrial Strain, Reproducibility, Right Atrial Strain, Septic Shock, Speckle Tracking, Transthoracic Echocardiography

Keywords

transthoracic echocardiography, septic shock, left atrial strain, right atrial strain, speckle tracking, echocardiographic software, AutoStrain, Bland-Altman analysis, reproducibility, critical care

Brief summary

Septic shock is a critical condition associated with high mortality. Transthoracic echocardiography is widely used to evaluate cardiac function and guide treatment. Left and right atrial strain (LAS and RAS) measured via speckle tracking echocardiography have shown prognostic value in cardiovascular diseases. However, differences exist between echocardiographic software, leading to challenges in result comparability. This study aims to compare LAS and RAS measurements between ECHOPAC and UWS software, evaluate AutoStrain technology, and assess reproducibility across observers. The study is non-interventional and will use retrospective echocardiographic data from patients treated for septic shock. The findings will contribute to improving measurement standardization in critically ill patients.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER
Henri Mondor University Hospital
CollaboratorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age: \>18 years * Adult patients admitted to critical care for septic shock (SEPSIS-3 definition) * TTE performed as part of medical management * No objection to data usage

Exclusion criteria

* Pregnancy * Moderate to severe valvular regurgitation/stenosis (\>grade 2) * Ventricular or supraventricular tachyarrhythmia (HR \>140 bpm) at the time of TTE * Poor echogenicity preventing LAS measurement * Mechanical circulatory support * Pacemaker dependence * Patients under guardianship

Design outcomes

Primary

MeasureTime frameDescription
variation of LASr between ECOPAC and UWS1 yearAgreement of LAS Reservoir Phase (LASr) measurement in manual mode between ECHOPAC and UWS

Secondary

MeasureTime frameDescription
variation of LAScd between ECHOPAC and UWS1 yearComparison of LAS Conduit (LAScd) measurements in manual mode between ECHOPAC and UWS
variation of LASct between ECHOPAC and UWS1 yearComparison of LAS Conduit (LAScd) and Contraction (LASct) measurements in manual mode between ECHOPAC and UWS
Comparison of LASr measurements in apical 2-chamber views1 yearComparison of LASr measurements in apical 2-chamber views in manual mode between ECHOPAC and UWS
Comparison of LAScd measurements in apical 2-chamber views1 yearComparison of LAScd measurements in apical 2-chamber views in manual mode between ECHOPAC and UWS
Comparison of LASct measurements in apical 2-chamber views1 yearComparison of LASct measurements in apical 2-chamber views in manual mode between ECHOPAC and UWS
Comparison of right atrial strain RASr between ECHOPAC and UWS1 yearComparison of right atrial strain (RASr) in manual mode between ECHOPAC and UWS
Comparison of right atrial strain RAScd between ECHOPAC and UWS1 yearComparison of right atrial strain RAScd in manual mode between ECHOPAC and UWS
Comparison of right atrial strain RASct between ECHOPAC and UWS1 yearComparison of right atrial strain RASct in manual mode between ECHOPAC and UWS
Comparison of LAS in AutoStrain versus manual mode1 yearComparison of LAS measurements in AutoStrain versus manual mode on UWS
Comparison of RAS in AutoStrain versus manual mode1 yearComparison of RAS measurements in AutoStrain versus manual mode on UWS
Comparison of LAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC1 yearComparison of LAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC
Comparison of RAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC1 yearComparison of RAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC
Assessment of differences in LAS measurements at end-diastole between ECHOPAC and UWS1 yearAssessment of differences in LAS phase measurements between ECHOPAC and UWS
Assessment of differences in LAS measurements at pre-A between ECHOPAC and UWS1 yearAssessment of differences in LAS measurements at pre-A between ECHOPAC and UWS
Assessment of differences in RAS measurements at end-diastole between ECHOPAC and UWS1 yearAssessment of differences in RAS measurements at end-diastole between ECHOPAC and UWS
Assessment of differences in RAS measurements at pre-A between between ECHOPAC and UWS1 yearAssessment of differences in RAS measurements at pre-A between between ECHOPAC and UWS
Inter-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients1 yearInter-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients
Intra-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients1 yearIntra-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients
Inter-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients1 yearInter-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients
Intra-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients1 yearIntra-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients

Countries

France

Contacts

CONTACTChristophe Beyls, MD
beyls.christophe@chu-amiens.fr33+322087866

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026